REPRODUCTION, published by BIOSCIENTIFICA LTD, stands at the forefront of research in the fields of reproductive and developmental biology. With a focus on advancing our understanding of reproductive health and mechanisms, the journal has garnered an impressive reputation, consistently ranking in the first quartile for key categories including Embryology, Endocrinology, Obstetrics and Gynecology, and Reproductive Medicine in 2023. Notably, it holds an esteemed position in the Scopus rankings, with high percentiles that reflect its significant impact in the scientific community. The journal is committed to open access, promoting the broad dissemination of high-quality research to facilitate innovative discoveries and interdisciplinary collaboration. Situated in the United Kingdom, REPRODUCTION serves as a vital resource for researchers, professionals, and students eager to contribute to the evolving landscape of reproductive sciences and related fields.

BJOG - An International Journal of Obstetrics and Gynaecology is a leading peer-reviewed journal in the field of obstetrics and gynecology, published by Wiley in the United Kingdom. With a rich history dating back to 1902, this esteemed journal is recognized for its significant contribution to advancing clinical practice and research, consistently ranking in the top tier (Q1) of its category, according to the 2023 Scopus rankings. Representing the best of 209 journals in the discipline, BJOG is dedicated to publishing high-quality research and innovative insights that address critical issues in women's health. While not an open-access journal, it provides valuable access options for institutions and individuals to stay informed about the latest developments and evidence-based practices. The journal's commitment to disseminating cutting-edge research makes it an essential resource for clinicians, researchers, and academics aiming to improve health outcomes in obstetrics and gynecology.

The Journal of Ovarian Research, published by BMC, is a premier open access journal dedicated to advancing knowledge in the fields of Obstetrics and Gynecology as well as Oncology. Established in 2008, this journal is based in the United Kingdom and has garnered significant attention, evidenced by its impressive Q1 ranking in Obstetrics and Gynecology and Q2 in Oncology as per the 2023 category quartiles. The journal boasts a notable Scopus ranking, placing it at #32 out of 209 in its primary field, showcasing a staggering 84th percentile ranking, indicating its relevance and impact on ongoing research in these disciplines. By facilitating unrestricted access to high-quality research through its open access model, the Journal of Ovarian Research serves as a vital resource for researchers, clinicians, and students alike, fostering collaboration and innovation in ovarian health studies.

Obstetrician & Gynaecologist is a leading peer-reviewed journal dedicated to the field of obstetrics and gynecology, published by WILEY. With a strong focus on delivering high-quality research and insights, this journal serves as a vital resource for healthcare professionals, researchers, and students involved in women's health. Although it does not offer open access, the journal maintains a significant impact on clinical practices by publishing original research, reviews, and case studies that align with the latest advancements in obstetric and gynecological medicine. The ISSN for the journal is 1467-2561, and it can also be accessed through the E-ISSN 1744-4667. Located at 111 River St, Hoboken, NJ 07030-5774, the journal aims to enhance knowledge and foster dialogue among practitioners and researchers, thereby improving health outcomes for women worldwide.

The Journal of Maternal-Fetal & Neonatal Medicine, published by Taylor & Francis Ltd, is a leading multidisciplinary journal focused on the critical fields of obstetrics, gynecology, pediatrics, and perinatology. Since its inception, this journal has offered a platform for the dissemination of pioneering research and innovative clinical practices, bridging knowledge gaps and informing the future of maternal and neonatal health. With a commendable 2023 impact factor that places it in the Q2 category of both Obstetrics and Gynecology and Pediatrics, Perinatology and Child Health, it stands at the forefront of scientific discourse, attracting a global readership. The journal aims to provide high-quality articles that contribute significantly to patient care, clinical practices, and policy-making, ensuring relevance and applicability to both researchers and healthcare professionals. With comprehensive access options and an emphasis on the convergence of emerging research trends, the Journal of Maternal-Fetal & Neonatal Medicine remains an invaluable resource for anyone dedicated to advancing the health of mothers and their newborns.

Reproductive Biology is a premier academic journal published by Elsevier, dedicated to advancing the field of reproductive science. With an ISSN of 1642-431X and an E-ISSN of 2300-732X, this journal has been serving the scientific community since its inception in 2001. It notably holds a Q1 ranking in Animal Science and Zoology as of 2023, underscoring its significant impact and prominence in this domain. The journal encompasses a wide array of topics surrounding reproductive biology, including but not limited to endocrinology and developmental processes, making it an essential resource for researchers and practitioners. Although it operates under a traditional access model, its comprehensive scope offers valuable insights that contribute to advancements in reproductive health, animal conservation, and biotechnology. Published in the Netherlands, Reproductive Biology aims to foster interdisciplinary collaboration and innovation, ultimately enriching our understanding of reproductive mechanisms across various species. Researchers, professionals, and students alike will find this journal an indispensable platform for disseminating groundbreaking research and engaging with the latest findings in reproductive science.

HUMAN REPRODUCTION is a prestigious academic journal published by Oxford University Press, dedicated to advancing the field of reproductive medicine. With an impressive impact factor highlighting its significance, the journal ranks in the top quartile (Q1) for Obstetrics and Gynecology, Rehabilitation, and Reproductive Medicine, showcasing its crucial role in disseminating high-quality research. Founded in 1986, it has become a key resource for researchers, practitioners, and students interested in cutting-edge developments and innovative practices in human reproduction. Despite not currently offering open access, the journal continues to publish a wealth of peer-reviewed articles that contribute substantially to clinical knowledge and practice. With Scopus rankings placing it among the top journals in its categories, HUMAN REPRODUCTION remains an essential platform for discussion and dissemination of vital findings impacting reproductive health globally.

Reproductive and Developmental Medicine is a pioneering open-access journal dedicated to advancing knowledge in the fields of reproductive medicine and developmental biology. Published by LIPPINCOTT WILLIAMS & WILKINS, the journal serves as a platform for researchers, clinicians, and graduate students alike, fostering collaboration and dissemination of innovative research findings. With an ISSN of 2096-2924 and E-ISSN 2589-8728, it has established a significant presence in the academic community since its inception in 2017. The journal is indexed in Scopus and achieved a category quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine as of 2023, highlighting its importance as a resource for cutting-edge studies and reviews in these vital areas. The journal's open-access model ensures that research is readily available to scholars and practitioners worldwide, thus enhancing the global discourse in reproductive health and development. This makes Reproductive and Developmental Medicine an invaluable resource for those dedicated to improving outcomes in obstetrics, gynecology, and reproductive health.

GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.

HUMAN REPRODUCTION UPDATE, published by Oxford University Press, stands as a leading journal in the fields of Obstetrics and Gynecology and Reproductive Medicine. With an impressive Q1 ranking in both categories according to the 2023 category quartiles and a significant Scopus rank, it is recognized as one of the top journals globally in these disciplines, catering to the most relevant and cutting-edge research. The journal has been a crucial platform for disseminating vital findings and reviews from 1995 to 2024, contributing to advancements in human reproductive health. With its focus on publishing high-quality, peer-reviewed articles, it serves as an essential resource for researchers, healthcare professionals, and students seeking the latest insights and developments in reproductive science. As the journal aims to foster informed discussions and encourage further research, it remains committed to shaping the future of reproductive health and medicine.